全文获取类型
收费全文 | 1474篇 |
免费 | 107篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 14篇 |
妇产科学 | 11篇 |
基础医学 | 218篇 |
口腔科学 | 10篇 |
临床医学 | 81篇 |
内科学 | 449篇 |
皮肤病学 | 44篇 |
神经病学 | 51篇 |
特种医学 | 61篇 |
外科学 | 300篇 |
综合类 | 5篇 |
预防医学 | 36篇 |
眼科学 | 14篇 |
药学 | 104篇 |
肿瘤学 | 194篇 |
出版年
2024年 | 3篇 |
2023年 | 15篇 |
2022年 | 25篇 |
2021年 | 43篇 |
2020年 | 29篇 |
2019年 | 39篇 |
2018年 | 52篇 |
2017年 | 50篇 |
2016年 | 45篇 |
2015年 | 32篇 |
2014年 | 60篇 |
2013年 | 71篇 |
2012年 | 97篇 |
2011年 | 125篇 |
2010年 | 74篇 |
2009年 | 64篇 |
2008年 | 71篇 |
2007年 | 93篇 |
2006年 | 92篇 |
2005年 | 76篇 |
2004年 | 100篇 |
2003年 | 72篇 |
2002年 | 60篇 |
2001年 | 27篇 |
2000年 | 12篇 |
1999年 | 25篇 |
1998年 | 17篇 |
1997年 | 18篇 |
1996年 | 13篇 |
1995年 | 6篇 |
1994年 | 8篇 |
1993年 | 9篇 |
1992年 | 10篇 |
1991年 | 9篇 |
1990年 | 12篇 |
1989年 | 9篇 |
1988年 | 4篇 |
1987年 | 2篇 |
1986年 | 4篇 |
1985年 | 4篇 |
1984年 | 3篇 |
1983年 | 4篇 |
1981年 | 2篇 |
1980年 | 3篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1974年 | 1篇 |
1972年 | 1篇 |
排序方式: 共有1594条查询结果,搜索用时 15 毫秒
11.
12.
13.
Miyaaki H Ichikawa T Yatsuhashi H Taura N Miuma S Usui T Mori S Kamihira S Tanaka Y Mizokami M Nakao K 《Hepatology research》2011,41(12):1216-1222
Aim: The aim of this study was to investigate the relationship among the expression of suppressor of cytokine signaling 3 (SOCS 3) in the liver, the SNPs in the IL28B locus, and the outcome of interferon therapy. Methods: Prior to interferon treatment, we immunostained 67 liver specimens from chronic hepatitis C (CHC) patients who were receiving peginterferon alpha‐2b/ribavirin therapy for suppressor of cytokine signaling 3 (SOCS3), and compared the expression of SOCS3, IL28 polymorphisms and other clinical factors between the patients and compared their eventual outcomes. Results: Significant differences between the low SOCS3 group and high SOCS3 group were found in age, as well as in the platelet, transaminase, gamma‐glutamyl transpeptidase levels. The incidence of high SOCS3 was not significantly different between subjects with the TT genotype and the TG genotype (TT : TG = 71%:29%, P = 0.250). In a multivariate analysis, age (≥65 years old) (odds ratio 0.221 [0.120–0.966], P = 0.045), IL28B gene (genotype TT) (odds ratio 5.422 [1.254–23.617], P = 0.024) and SOCS3 (high) (odds ratio 0.308 [0.104–0.948], P = 0.040) were significant predictors of the interferon response. In patients with the TT genotype, those with low SOCS3 immunostaining showed a high sustained virological response (69%), while the sustained virological rate was low (27%) in the patients with high SOCS3 immunostaining. Conclusions: Using a combination of the SOCS3 immunostained area in the liver and the expression of IL28B single nucleotide polymorphisms might be a useful predictor of hepatitis C virus clearance by interferon therapy. 相似文献
14.
15.
16.
Mayu Isotani Osamu Yamada Joshua L. Lachowicz Kyoichi Tamura Hiroko Yagihara Yasuhito Fujino Kenichiro Ono Tsukimi Washizu Makoto Bonkobara 《British journal of haematology》2010,148(1):144-153
The purpose of the current study was to investigate the mutation status of KIT in feline mast cell tumours (MCTs) and to examine the effects of tyrosine kinase inhibition on the phosphorylation of mutant kit in vitro and in clinical cases of cats. Sequence analysis of KIT identified mutations in 42/62 MCTs (67·7%). The vast majority of the mutations were distributed in exons 8 and 9, both of which encode the fifth immunoglobulin-like domain (IgD) of kit. All five types of kit with a mutation in the fifth IgD were then expressed in 293 cells and examined for phosphorylation status. The mutant kit proteins showed ligand-independent phosphorylation. The tyrosine kinase inhibitor imatinib mesylate suppressed the phosphorylation of these mutant kit proteins in transfectant cells. In a clinical study of 10 cats with MCTs, beneficial response to imatinib mesylate was observed in 7/8 cats that had a mutation in the fifth IgD of kit in tumour cells. Mutations in the fifth IgD of kit thus appear to be common and potentially sensitive to imatinib mesylate in feline MCTs. These data provide an in vivo model for paediatric mastocytosis where mutations in the fifth IgD of kit also occur. 相似文献
17.
Tanaka Y Takakura Y Taniguchi A Sugimoto K Kumai T Fukui A 《Modern rheumatology / the Japan Rheumatism Association》2004,14(2):130-134
Partial intertarsal joint arthrodesis was performed on 12 feet of 11 patients as a surgical treatment for planovalgus deformity of the foot and lesions of the intertarsal joints caused by rheumatoid arthritis. Single arthrodesis was performed on the talocalcaneal joint in eight feet, two of which underwent simultaneous total ankle arthroplasty, and on the talonavicular joint in two feet. Double arthrodesis was done on the talocalcaneal and talonavicular joints in one foot and on the talonavicular and calcaneocuboid joints in one foot. Screws or staples were used for fixation. Patients were followed for 2 years to 8 years 7 months (average 4 years 3 months). Osseous fusion was achieved in all feet, and satisfactory pain relief was obtained in all cases except one. We performed this surgery in patients who were relatively active, and the results indicated that arthrodesis of a small number of joints that caused pain and deformity was effective in reducing pain and correcting the deformity. We concluded that partial tarsal arthrodesis should be performed on a limited number of joints during the early stages of planovalgus deformity of the foot because more joints are found to be fixed during the advanced stages. However, progression of the osteoarthritis was found in the neighboring joints. Close follow-up observation is needed. 相似文献
18.
19.
Sakamoto Kazumasa Ito Kiyoaki Yotsuyanagi Hiroshi Yatsuhashi Hiroshi Tanaka Yasuhito Hige Shuhei Takikawa Yasuhiro Ueno Yoshiyuki Yamamoto Kazuhide Imazeki Fumio Inoue Jun Kurosaki Masayuki Umemura Takeji Toyoda Hidenori Mita Eiji Michitaka Kojiro Maeshiro Tatsuji Yamada Norie Suetsugu Atsushi Kawanaka Miwa Seko Yuya Matsuura Kentaro Okumura Akinori Fukuzawa Yoshitaka Sugiyama Masaya Mizokami Masashi Yoneda Masashi 《Journal of gastroenterology》2022,57(12):971-980
Journal of Gastroenterology - Hepatitis B virus (HBV) is one of the most prevalent chronic viral infections that causes chronic hepatitis B (CHB). In Japan, genotypes B and C account for most of... 相似文献